Publikationen W. Löscher

Drath, I., Richter, F., & Feja, M. (2025). Nose-to-brain drug delivery: from bench to bedside. Translational Neurodegeneration, 14, Article 23. https://doi.org/10.1186/s40035-025-00481-w
Details anzeigen
Hartke, A.-S., Schreiber, C. S., Lau, K., Wiesweg, I., Waltl, I., Kalinke, U., Richter, F., & Käufer, C. (2025). Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins. Neurobiology of Disease, 205, Article 106773. https://doi.org/10.1016/j.nbd.2024.106773
Details anzeigen
Käufer, C., Stanojlović, M., Schidlitzki, A., Bonsberger, J., Storch, A., & Richter, F. (2025). Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy. Journal of Parkinson’s Disease: JPD, 15(2), 311–328. https://doi.org/10.1177/1877718X241310723
Details anzeigen
Lai, T. T., Xiang, W., Stanojlovic, M., Käufer, C., Feja, M., Lau, K., Zunke, F., & Richter, F. (2025). The basolateral amygdala and striatum propagate alpha-synuclein pathology causing increased fear response in a Parkinson’s disease model. Brain, Behavior, and Immunity: An International Journal, 128, 469–486. https://doi.org/10.1016/j.bbi.2025.04.025
Details anzeigen
Schreiber, C. S., Ramil, L. N., Bieligk, J., Meineke, R., Käufer, C., & Richter, F. (2025). Intravenous SARS-CoV-2 Spike protein induces neuroinflammation and alpha-synuclein accumulation in brain regions relevant to Parkinson’s disease. Brain, Behavior, and Immunity: An International Journal. https://doi.org/10.1016/j.bbi.2025.05.021
Details anzeigen
Lau, K., Kotzur, R., & Richter, F. (2024). Blood-brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy. Translational Neurodegeneration, 13, Article 37. https://doi.org/10.1186/s40035-024-00430-z
Details anzeigen
Lüttig, A., Perl, S., Zetsche, M., Richter, F., Franz, D., Heerdegen, M., Köhling, R., & Richter, A. (2024). Short-term stimulations of the entopeduncular nucleus induce cerebellar changes of c-Fos expression in an animal model of paroxysmal dystonia. Brain Research, 1823, Article 148672. https://doi.org/10.1016/j.brainres.2023.148672
Details anzeigen
Mercado, G., Kaeufer, C., Richter, F., & Peelaerts, W. (2024). Infections in the etiology of Parkinson’s disease and synucleinopathies: a renewed perspective, mechanistic insights, and therapeutic implications. Journal of Parkinson’s Disease: JPD, 14(7), 1301–1329. https://doi.org/10.3233/JPD-240195
Details anzeigen
Schreiber, C. S., Wiesweg, I., Stanelle-Bertram, S., Beck, S., Kouassi, N. M., Schaumburg, B., Gabriel, G., Richter, F., & Käufer, C. (2024). Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model. EBioMedicine, 105, Article 105191. https://doi.org/10.1016/j.ebiom.2024.105191
Details anzeigen
Thi Lai, T., Kim, Y. E., Nguyen, L. T. N., Thi Nguyen, T., Kwak, I. H., Richter, F., Kim, Y. J., & Ma, H.-I. (2024). Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model. Npj Parkinson’s Disease, 10(1), Article 32. https://doi.org/10.1038/s41531-024-00640-2
Details anzeigen